Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(3.39)
# 1,029
Out of 4,980 analysts
387
Total ratings
43.19%
Success rate
5.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $22.51 | +122.12% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.69 | +225.20% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $468.58 | +21.64% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $5.24 | +663.36% | 17 | Aug 4, 2025 | |
| ATAI Atai Life Sciences | Maintains: Buy | $10 → $15 | $4.60 | +226.09% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $3.93 | +154.45% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.23 | +306.50% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.53 | +1,780.41% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $4.88 | +1,436.89% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $36.48 | +174.12% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $16.94 | +313.22% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.31 | +281.68% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.98 | +1,104.82% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $29.72 | +169.18% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $12.48 | +220.51% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.38 | +584.93% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $33.42 | +109.46% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $21.55 | +271.23% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.91 | +423.56% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.46 | +189.02% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $9.65 | +469.95% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.23 | +2,003.25% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $49.38 | +72.13% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $6.01 | +2,395.84% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $14.00 | +385.71% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $191.80 | +77.27% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $22.51
Upside: +122.12%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.69
Upside: +225.20%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $468.58
Upside: +21.64%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $5.24
Upside: +663.36%
Atai Life Sciences
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.60
Upside: +226.09%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $3.93
Upside: +154.45%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.23
Upside: +306.50%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.53
Upside: +1,780.41%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $4.88
Upside: +1,436.89%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $36.48
Upside: +174.12%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $16.94
Upside: +313.22%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.31
Upside: +281.68%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.98
Upside: +1,104.82%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $29.72
Upside: +169.18%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.48
Upside: +220.51%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.38
Upside: +584.93%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $33.42
Upside: +109.46%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $21.55
Upside: +271.23%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.91
Upside: +423.56%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.46
Upside: +189.02%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $9.65
Upside: +469.95%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.23
Upside: +2,003.25%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $49.38
Upside: +72.13%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $6.01
Upside: +2,395.84%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $14.00
Upside: +385.71%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $191.80
Upside: +77.27%